CARDIFF ONCOLOGY, INC. (CRDF) Operating income 2016–2025
CARDIFF ONCOLOGY, INC. (CRDF) annual operating income history from SEC filings — each fiscal year as reported.
-$49.0MFY2025 · since FY2016: -$40.1M → -$49.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$49.0M | -0.6% |
| FY2024 | -$48.7M | -7.1% |
| FY2023 | -$45.4M | -13.8% |
| FY2022 | -$39.9M | -38.3% |
| FY2021 | -$28.9M | -51.2% |
| FY2020 | -$19.1M | -14.4% |
| FY2019 | -$16.7M | +2.2% |
| FY2018 | -$17.1M | +33.4% |
| FY2017 | -$25.6M | +36.2% |
| FY2016 | -$40.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice